In this post, Sitero summarizes the most recent amendments to the NIH Guidelines, covering key changes for GDMOs. Learn more in the blog:
Learn about the history and common challenges of human subject research compliance and how organizations can navigate this intricate landscape in our latest blog post:
Stay informed about the latest proposed changes to select agent regulations and discover the significant updates outlined in the latest biennial review summarized in our latest blog post:
Explore the power of EDC systems in clinical research. From enhanced accuracy to streamlined processes, discover how Sitero's EDC suite is shaping the future of data management. Learn more about EDC in our recent blog:
By understanding the value that biosafety adds to research and science, we can navigate the path toward a safer and more robust scientific research environment. Learn more in the blog:
We developed this blog as a practical guide for sponsors, CROs, research institutions, and ethics committees (ECs) to successfully adopt eConsent. Learn more:
Although the overall benefits of these products likely outweigh their potential risks, the FDA is investigating the risk of T-cell malignancy with serious outcomes. Read our summary of the recent FDA update here:
The integrity and trustworthiness of research fundamentally depends on the ethical decisions made by IRBs. Learn more in the blog:
The collaboration between scientists & biosafety committees is a cornerstone of responsible, safe, and impactful research. Learn more:
Read our summary of the proposed updates to the NIH Guidelines. Public comments are only open until Oct 10th. Join the conversation and make your input count!
Blogrobgjryan2023-11-02T16:23:27+00:00